IL6 and metabolic syndrome: Higher levels of CRP, high sensitivity CRP (hsCRP), and IL-6 have consistently been associated with an increased risk of insulin resistance [19–21], hyperinsulinism [20, 22], impaired glucose tolerance [23–25], type 2 diabetes [10, 23, 26–30], and metabolic syndrome [31, 32].